Hana Müllerová,1 Wilhelmine H Meeraus,1 Dmitry V Galkin,2 Frank C Albers,2 Sarah H Landis1,31Respiratory Epidemiology, GSK, Uxbridge, UK; 2Respiratory Medical Franchise, GSK, Uxbridge, NC, USA; 3Patient Centered Outcomes and Value Evidence and Outcomes, GSK, Collegeville, PA, USABackground: There are currently limited real-world data on
Empedobacter brevis is gram-negative bacilli that belongs to Flavobacteriaceae family.It was previously known with name of Flavobacterium breve.The reservoir of these bacteria is soil, plants, water, food, hospital water sources, including incubators, sinks, faucets, tap water, hemodialysis systems, saline solutions, and other pharmaceutical soluti
ABSTRACT Objective: Many biologic agents cause some degree of immunosuppression, which can increase the risk of reactivation of tuberculosis infection (TBI).This risk is variable between individual biologics.We aimed to assess current (and recommended) clinical practice of TBI screening and treatment among patients initiating treatment with biologi